[1]龚建程,陈圣华,徐卫国,等.仙灵骨葆联合阿伦膦酸钠治疗肾阳亏虚型骨质疏松症的临床研究[J].中医正骨,2012,24(05):7-9.
　GONG Jian-cheng*,CHEN Sheng-hua,XU Wei-guo,et al.Clinical study on“xian ling gu bao”plus alendronate in treating osteoporosis of insufficiency of the kidney-Yang[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(05):7-9.
点击复制

仙灵骨葆联合阿伦膦酸钠治疗肾阳亏虚型骨质疏松症的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第24卷
期数:
2012年05期
页码:
7-9
栏目:
临床研究
出版日期:
2012-05-20

文章信息/Info

Title:
Clinical study on“xian ling gu bao”plus alendronate in treating osteoporosis of insufficiency of the kidney-Yang
作者:
龚建程; 陈圣华; 徐卫国; 鲁光钱
温州医学院附属第三医院,浙江 瑞安 325200
Author(s):
GONG Jian-cheng*; CHEN Sheng-hua; XU Wei-guo; LU Guang-qian.
*The Third Affiliated Hospital of Wenzhou Medical College,Rui'an 325200,Zhejiang,China
关键词:
骨质疏松 肾阳虚 仙灵骨葆 阿伦膦酸钠
Keywords:
Osteoporosis;  KIDNEY-YANG DEFICIENCY;  xian ling gu bao;  alendronate
摘要:
目的:观察研究仙灵骨葆联合阿伦膦酸钠治疗肾阳亏虚型骨质疏松症的临床疗效。方法:通过随机对照试验设计,对90例肾阳亏虚型骨质疏松症患者分组,在常规治疗的基础上,设立治疗组(仙灵骨葆联合阿伦膦酸钠)及2组对照组(仙灵骨葆组A、阿伦膦酸钠组B),观察临床疗效、肾阳亏虚型症状及骨密度改变。结果:治疗后三组均有疗效,治疗组和对照组A及对照组B比较,均有统计学意义,治疗组疗效显著优于对照组, 肾阳亏虚型症状及骨密度均有显著改变(P<0.001),而且治疗组优于对照组。结论:仙灵骨葆联合阿伦膦酸钠治疗肾阳亏虚型骨质疏松症方面有良好的疗效。
Abstract:
Objective:To study the clinical effects of xian ling gu bao plus alendronate on osteoporosis of insufficiency of the kidney-Yang.Methods:By random number generating method, 90 osteoporosis of insufficiency of the kidney-Yang patients were randomly divided into a treatment group with xian ling gu bao plus alendronate, control group A only with xian ling gu bao, and control group B only with alendronate. To investigate the change of the clinical effects, the symptom of insufficiency of the kidney-Yang and the bone mineral density(BMD)after recording of the treatments. Results:There were significant differences before and after treatment, between treatment group and the control group A, between treatment group and the control group B.There were significant differences between the treatment groups and the control groups. There was significant difference about the symptom of insufficiency of the kidney-Yang and the bone mineral density(BMD)after recording of the treatments(P<0.001), and the treatment group was better than the control group.Conclusions:xian ling gu bao plus alendronate has definite therapeutic effects on osteoporosis of insufficiency of the kidney-Yang.

参考文献/References:

[1] 李跃华,薛李,赵芳芳,等.原发性骨质疏松症中医证型分布及其与骨折关系研究[J].中国中西医结合杂志,2010,5(30):5.
[2] 中华医学会.原发性骨质疏松症诊疗指南[M].北京:人民卫生出版社,2007,12(1):3.
[3] 刘忠厚,杨定焯,朱汉民,等.中国人骨质疏松症建议诊断标准(第2稿)[J].中国骨质疏松杂志,2000,6(1):1.
[4] 郑莜萸.中药新药临床研究指导原则[S].中国医药科技出版社,2002,5:356-360.
[5] 杨彬.胰岛素样生长因子-1的研究进展[J].广西医学,2002,24( 8):1198-1201.
[6] Cranney A,Guyatt G,GriffithL,et al.Meta-analyses of therapies for postmenop-ausal osteoporosis.IX:Summary of meta-analyses of thera-pies for postmenopausal osteoporosis[J].Endocr Rev,2002,23(4):570-578.

更新日期/Last Update: 2012-05-20